Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer

Trial Profile

An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 May 2017

At a glance

  • Drugs Bevacizumab (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 May 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Dec 2013 to 1 Dec 2015.
    • 17 May 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Dec 2013 to 1 Dec 2015.
    • 24 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top